| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CCR4-NOT complex binding | 6.28e-05 | 3 | 92 | 2 | GO:1905762 | |
| GeneOntologyMolecularFunction | microtubule binding | 8.86e-05 | 308 | 92 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | NUSAP1 KIF21B ALMS1 NUMA1 CCSER2 RAB11FIP5 TOGARAM1 KIF4B FHDC1 | 1.59e-04 | 428 | 92 | 9 | GO:0015631 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.16e-04 | 118 | 92 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX47 KIF21B MYH8 MYH11 ATP7A MYO10 ABCB5 KIF4B RUVBL2 ABCA10 | 5.26e-04 | 614 | 92 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 6.99e-04 | 231 | 92 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.10e-04 | 38 | 92 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | retromer complex binding | 9.22e-04 | 10 | 92 | 2 | GO:1905394 | |
| GeneOntologyCellularComponent | early endosome membrane | 4.22e-05 | 212 | 92 | 7 | GO:0031901 | |
| GeneOntologyCellularComponent | euchromatin | 2.88e-04 | 72 | 92 | 4 | GO:0000791 | |
| Domain | Histone_H5 | 6.57e-06 | 8 | 93 | 3 | IPR005819 | |
| Domain | FAM21 | 2.45e-05 | 2 | 93 | 2 | IPR027308 | |
| Domain | H15 | 3.30e-05 | 13 | 93 | 3 | SM00526 | |
| Domain | Linker_histone | 3.30e-05 | 13 | 93 | 3 | PF00538 | |
| Domain | H15 | 3.30e-05 | 13 | 93 | 3 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 4.18e-05 | 14 | 93 | 3 | IPR005818 | |
| Domain | FAM21/CAPZIP | 7.33e-05 | 3 | 93 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 7.33e-05 | 3 | 93 | 2 | PF15255 | |
| Domain | RCC1 | 1.28e-04 | 20 | 93 | 3 | PF00415 | |
| Domain | RCC1_1 | 1.49e-04 | 21 | 93 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.49e-04 | 21 | 93 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.49e-04 | 21 | 93 | 3 | PS50012 | |
| Domain | Reg_chr_condens | 1.72e-04 | 22 | 93 | 3 | IPR000408 | |
| Domain | - | 1.72e-04 | 22 | 93 | 3 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 1.97e-04 | 23 | 93 | 3 | IPR009091 | |
| Domain | Myosin_head_motor_dom | 8.89e-04 | 38 | 93 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 8.89e-04 | 38 | 93 | 3 | PS51456 | |
| Domain | Myosin_head | 8.89e-04 | 38 | 93 | 3 | PF00063 | |
| Domain | MYSc | 8.89e-04 | 38 | 93 | 3 | SM00242 | |
| Domain | P-loop_NTPase | DDX47 KIF21B MYH8 MYH11 MYO10 ABCB5 GNL2 KIF4B RASL12 PFKFB3 RUVBL2 ABCA10 | 1.01e-03 | 848 | 93 | 12 | IPR027417 |
| Domain | Myosin_N | 2.47e-03 | 15 | 93 | 2 | PF02736 | |
| Domain | Myosin_N | 2.47e-03 | 15 | 93 | 2 | IPR004009 | |
| Domain | Myosin_tail_1 | 3.56e-03 | 18 | 93 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.56e-03 | 18 | 93 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 3.97e-03 | 19 | 93 | 2 | IPR027401 | |
| Domain | - | 3.97e-03 | 19 | 93 | 2 | 4.10.270.10 | |
| Domain | FA58C | 4.84e-03 | 21 | 93 | 2 | SM00231 | |
| Domain | FA58C_3 | 4.84e-03 | 21 | 93 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.84e-03 | 21 | 93 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.84e-03 | 21 | 93 | 2 | PS01286 | |
| Domain | IQ | 5.35e-03 | 71 | 93 | 3 | PF00612 | |
| Domain | F5_F8_type_C | 6.30e-03 | 24 | 93 | 2 | PF00754 | |
| Domain | FA58C | 6.30e-03 | 24 | 93 | 2 | IPR000421 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 9.36e-07 | 17 | 65 | 4 | M27189 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 2.59e-05 | 13 | 65 | 3 | M1018 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 4.09e-05 | 15 | 65 | 3 | MM14902 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 26209608 | ||
| Pubmed | High-resolution mapping of h1 linker histone variants in embryonic stem cells. | 1.85e-08 | 3 | 93 | 3 | 23633960 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 21245380 | ||
| Pubmed | H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. | 7.39e-08 | 4 | 93 | 3 | 12808097 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 11746507 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 10997781 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 11689686 | ||
| Pubmed | The mouse histone H1 genes: gene organization and differential regulation. | 1.84e-07 | 5 | 93 | 3 | 9300059 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 11467742 | ||
| Pubmed | A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. | 1.84e-07 | 5 | 93 | 3 | 8003976 | |
| Pubmed | Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. | 1.84e-07 | 5 | 93 | 3 | 10893414 | |
| Pubmed | Expression of murine H1 histone genes during postnatal development. | 1.84e-07 | 5 | 93 | 3 | 9655912 | |
| Pubmed | GARIN5B C9orf43 MYH8 MYH11 TBC1D31 ABCB5 NUMA1 H1-2 H1-3 H1-4 MARF1 ERC2 RPS19 PRX FER1L6 RYR2 VAMP3 | 2.51e-07 | 1442 | 93 | 17 | 35575683 | |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 3.68e-07 | 6 | 93 | 3 | 15595731 | |
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 15562002 | ||
| Pubmed | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. | 3.68e-07 | 6 | 93 | 3 | 21425800 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 3.68e-07 | 6 | 93 | 3 | 11479299 | |
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 3.68e-07 | 6 | 93 | 3 | 9499577 | |
| Pubmed | Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway. | 3.68e-07 | 6 | 93 | 3 | 22083958 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 3.68e-07 | 6 | 93 | 3 | 15911621 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 24435047 | ||
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 6.43e-07 | 7 | 93 | 3 | 8325638 | |
| Pubmed | 1.01e-06 | 503 | 93 | 10 | 36217030 | ||
| Pubmed | Histone h1 depletion impairs embryonic stem cell differentiation. | 1.03e-06 | 8 | 93 | 3 | 22589736 | |
| Pubmed | 1.08e-06 | 29 | 93 | 4 | 34175335 | ||
| Pubmed | NUSAP1 PHF2 MED24 PBRM1 UBN1 ALMS1 INO80C NUMA1 MARF1 GNL2 RPS19 HERC2 WASHC2A RUVBL2 GARRE1 RAI2 | 1.17e-06 | 1429 | 93 | 16 | 35140242 | |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 2.19e-06 | 10 | 93 | 3 | 28794128 | |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 2.19e-06 | 10 | 93 | 3 | 15927069 | |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 3.01e-06 | 11 | 93 | 3 | 26689747 | |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 4.00e-06 | 12 | 93 | 3 | 22650316 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | WASHC2C UBN1 ALMS1 RAB11FIP5 ERC2 RPS19 WASHC2A RUVBL2 GARRE1 FAM83B | 4.06e-06 | 588 | 93 | 10 | 38580884 |
| Pubmed | 5.19e-06 | 13 | 93 | 3 | 8858344 | ||
| Pubmed | NUSAP1 MED24 DPAGT1 TBC1D31 WASHC2C ARHGAP26 CCSER2 PHTF2 GEMIN5 WASHC2A NFAT5 TUB TIAM2 | 6.30e-06 | 1084 | 93 | 13 | 11544199 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 24873882 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31150793 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23172129 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15847701 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26807827 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20827171 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 7.07e-06 | 2 | 93 | 2 | 36717248 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15158464 | ||
| Pubmed | 8.85e-06 | 272 | 93 | 7 | 31010829 | ||
| Pubmed | 1.01e-05 | 16 | 93 | 3 | 33288900 | ||
| Pubmed | 1.74e-05 | 19 | 93 | 3 | 25355947 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PLEKHG1 TBC1D31 WASHC2C ALMS1 CARMIL1 H1-2 HERC2 WASHC2A RUVBL2 GARRE1 FAM83B | 1.77e-05 | 853 | 93 | 11 | 28718761 |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 2613692 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 24525734 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 18056081 | ||
| Pubmed | NFAT5 promotes oral squamous cell carcinoma progression in a hyperosmotic environment. | 2.12e-05 | 3 | 93 | 2 | 32901097 | |
| Pubmed | 3.15e-05 | 23 | 93 | 3 | 31748650 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.66e-05 | 759 | 93 | 10 | 35915203 | |
| Pubmed | Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis. | 4.23e-05 | 4 | 93 | 2 | 29993000 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 19072710 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 35750275 | ||
| Pubmed | Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement. | 4.23e-05 | 4 | 93 | 2 | 8589518 | |
| Pubmed | DDX47 PHF2 SOWAHA PBRM1 ALMS1 INO80C H1-2 H1-4 GNL2 RAB11FIP5 RUVBL2 GARRE1 | 4.28e-05 | 1116 | 93 | 12 | 31753913 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 4.42e-05 | 621 | 93 | 9 | 22794259 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX47 NUSAP1 MYH11 MYO10 NUMA1 H1-2 H1-3 H1-4 GNL2 RAB11FIP5 RPS19 | 4.68e-05 | 949 | 93 | 11 | 36574265 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 4.70e-05 | 626 | 93 | 9 | 33644029 | |
| Pubmed | 5.13e-05 | 244 | 93 | 6 | 29884807 | ||
| Pubmed | 5.78e-05 | 28 | 93 | 3 | 26381412 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | FANCE NUSAP1 PBRM1 WASHC2C CARMIL1 NUMA1 CCSER2 KIF4B HERC2 WASHC2A RUVBL2 FAM83B | 5.95e-05 | 1155 | 93 | 12 | 20360068 |
| Pubmed | 7.05e-05 | 660 | 93 | 9 | 32780723 | ||
| Pubmed | DDX47 NUSAP1 PHF2 MYH11 PBRM1 INO80C NUMA1 STON2 MARF1 GNL2 HERC2 TRUB1 RUVBL2 | 7.26e-05 | 1371 | 93 | 13 | 36244648 | |
| Pubmed | 14-3-3sigma controls mitotic translation to facilitate cytokinesis. | 8.60e-05 | 86 | 93 | 4 | 17361185 | |
| Pubmed | KIF21B ARHGAP26 SETBP1 CCSER2 RAB11FIP5 GARRE1 KIAA1614 TIAM2 | 8.92e-05 | 529 | 93 | 8 | 14621295 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 9.09e-05 | 847 | 93 | 10 | 35235311 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 9.40e-05 | 533 | 93 | 8 | 30554943 | |
| Pubmed | Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. | 9.41e-05 | 88 | 93 | 4 | 20618440 | |
| Pubmed | 9.41e-05 | 88 | 93 | 4 | 26318153 | ||
| Pubmed | 1.00e-04 | 538 | 93 | 8 | 28524877 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.05e-04 | 6 | 93 | 2 | 34143959 | |
| Pubmed | 1.14e-04 | 407 | 93 | 7 | 12693553 | ||
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 1.35e-04 | 37 | 93 | 3 | 36835656 | |
| Pubmed | 1.36e-04 | 419 | 93 | 7 | 15635413 | ||
| Pubmed | Placentation defects are highly prevalent in embryonic lethal mouse mutants. | 1.73e-04 | 103 | 93 | 4 | 29539633 | |
| Pubmed | 1.80e-04 | 104 | 93 | 4 | 9205841 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.84e-04 | 440 | 93 | 7 | 34244565 | |
| Pubmed | 1.86e-04 | 441 | 93 | 7 | 31239290 | ||
| Pubmed | 1.96e-04 | 8 | 93 | 2 | 27378146 | ||
| Pubmed | A FAM21-containing WASH complex regulates retromer-dependent sorting. | 1.96e-04 | 8 | 93 | 2 | 19922874 | |
| Pubmed | 2.00e-04 | 446 | 93 | 7 | 24255178 | ||
| Pubmed | 2.11e-04 | 43 | 93 | 3 | 22701719 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.21e-04 | 203 | 93 | 5 | 22083510 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.31e-04 | 608 | 93 | 8 | 36089195 | |
| Pubmed | 2.42e-04 | 45 | 93 | 3 | 33596420 | ||
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 2.52e-04 | 9 | 93 | 2 | 24412544 | |
| Pubmed | 2.52e-04 | 9 | 93 | 2 | 23645681 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 2.67e-04 | 468 | 93 | 7 | 36042349 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.92e-04 | 475 | 93 | 7 | 31040226 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 3.07e-04 | 218 | 93 | 5 | 35831895 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 3.22e-04 | 639 | 93 | 8 | 23443559 | |
| Pubmed | 3.23e-04 | 483 | 93 | 7 | 36912080 | ||
| Pubmed | 3.41e-04 | 123 | 93 | 4 | 35583604 | ||
| Pubmed | 3.55e-04 | 225 | 93 | 5 | 12168954 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.58e-04 | 349 | 93 | 6 | 25665578 | |
| Pubmed | 3.66e-04 | 493 | 93 | 7 | 15368895 | ||
| Pubmed | 3.71e-04 | 653 | 93 | 8 | 22586326 | ||
| Pubmed | 3.72e-04 | 52 | 93 | 3 | 9455477 | ||
| Pubmed | 3.79e-04 | 655 | 93 | 8 | 35819319 | ||
| Interaction | BSN interactions | 1.83e-05 | 35 | 91 | 4 | int:BSN | |
| Interaction | CEP135 interactions | 3.21e-05 | 272 | 91 | 8 | int:CEP135 | |
| Interaction | H2AC18 interactions | 5.65e-05 | 148 | 91 | 6 | int:H2AC18 | |
| Interaction | TBX1 interactions | 5.79e-05 | 17 | 91 | 3 | int:TBX1 | |
| Interaction | CEP128 interactions | 5.97e-05 | 297 | 91 | 8 | int:CEP128 | |
| Interaction | SFN interactions | MYH11 ALMS1 NEK8 CARMIL1 H1-2 CCSER2 H1-3 RABGEF1 RPS19 RUVBL2 GARRE1 FAM83B | 6.44e-05 | 692 | 91 | 12 | int:SFN |
| Interaction | BFAR interactions | 6.50e-05 | 48 | 91 | 4 | int:BFAR | |
| Cytoband | 8q24.1 | 8.47e-05 | 7 | 93 | 2 | 8q24.1 | |
| Cytoband | 2p13 | 9.99e-04 | 23 | 93 | 2 | 2p13 | |
| Cytoband | 16p13.11 | 9.99e-04 | 23 | 93 | 2 | 16p13.11 | |
| GeneFamily | WASH complex | 1.45e-04 | 6 | 57 | 2 | 1331 | |
| GeneFamily | Myosin heavy chains | 9.99e-04 | 15 | 57 | 2 | 1098 | |
| GeneFamily | INO80 complex |SRCAP complex | 9.99e-04 | 15 | 57 | 2 | 595 | |
| Coexpression | GHANDHI_BYSTANDER_IRRADIATION_DN | 9.00e-06 | 12 | 92 | 3 | M2599 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.66e-07 | 193 | 93 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.66e-07 | 193 | 93 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-07 | 155 | 93 | 6 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.09e-06 | 179 | 93 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-06 | 182 | 93 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-06 | 186 | 93 | 6 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.60e-06 | 186 | 93 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.69e-06 | 187 | 93 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.86e-06 | 189 | 93 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.86e-06 | 189 | 93 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.86e-06 | 189 | 93 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-06 | 193 | 93 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.32e-06 | 194 | 93 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.42e-06 | 195 | 93 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-06 | 200 | 93 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 158 | 93 | 5 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 170 | 93 | 5 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 175 | 93 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 175 | 93 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 176 | 93 | 5 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-05 | 181 | 93 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.54e-05 | 187 | 93 | 5 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 187 | 93 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.54e-05 | 187 | 93 | 5 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.54e-05 | 187 | 93 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 188 | 93 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 4.66e-05 | 188 | 93 | 5 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-05 | 189 | 93 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.90e-05 | 190 | 93 | 5 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.90e-05 | 190 | 93 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 191 | 93 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.02e-05 | 191 | 93 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.02e-05 | 191 | 93 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 5.15e-05 | 192 | 93 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-05 | 192 | 93 | 5 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.15e-05 | 192 | 93 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-05 | 192 | 93 | 5 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-05 | 192 | 93 | 5 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.28e-05 | 193 | 93 | 5 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.28e-05 | 193 | 93 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.28e-05 | 193 | 93 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 193 | 93 | 5 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 5.41e-05 | 194 | 93 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-05 | 195 | 93 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 195 | 93 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-05 | 195 | 93 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | COVID-19_Mild-Non-classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 5.54e-05 | 195 | 93 | 5 | dd00facd20a661ef23fa7fd9a02ee377b8f2d1b9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.54e-05 | 195 | 93 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | COVID-19_Mild-Non-classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class | 5.54e-05 | 195 | 93 | 5 | 0295d9897830987eec74f51178e14fb0a83723dc | |
| ToppCell | Control-Non-classical_Monocyte-|Control / Disease condition and Cell class | 5.68e-05 | 196 | 93 | 5 | b17ab094cdc7050c2997e24ed474779b5d6f6146 | |
| ToppCell | Control-Non-classical_Monocyte|Control / Disease condition and Cell class | 5.68e-05 | 196 | 93 | 5 | 404064ccfe2cb73df7a7f88aa65d86b97dcef9d4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.68e-05 | 196 | 93 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.82e-05 | 197 | 93 | 5 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 197 | 93 | 5 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 197 | 93 | 5 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.82e-05 | 197 | 93 | 5 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.96e-05 | 198 | 93 | 5 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-05 | 198 | 93 | 5 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-05 | 198 | 93 | 5 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.96e-05 | 198 | 93 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.25e-05 | 200 | 93 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-05 | 200 | 93 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 6.25e-05 | 200 | 93 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 6.25e-05 | 200 | 93 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-05 | 200 | 93 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-05 | 200 | 93 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.17e-04 | 141 | 93 | 4 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.17e-04 | 141 | 93 | 4 | a32947b13e888850c979a54c137512e4b96d2f36 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.17e-04 | 141 | 93 | 4 | 2cb651d63466fdcce011d1dd8de409ef439d03e7 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 142 | 93 | 4 | c3a5a80f78704d34db5df85d6e3e8fc84ff24268 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.68e-04 | 149 | 93 | 4 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.68e-04 | 149 | 93 | 4 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 2.97e-04 | 153 | 93 | 4 | 654265f3c14344071b2af7ca05cbdbb17ce2c5d3 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 2.97e-04 | 153 | 93 | 4 | 105b91f5277d145f7717307d7eb9b7d8e8e23576 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 157 | 93 | 4 | 10989c7046fc859f137c7cef3296508d4476f11f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 158 | 93 | 4 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.60e-04 | 161 | 93 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-04 | 161 | 93 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 163 | 93 | 4 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | droplet-Spleen-nan-24m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 164 | 93 | 4 | 4d8233f69ea89d4104caa56bdd0c23c27cabe9b3 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 3.95e-04 | 165 | 93 | 4 | ecaeb90a6bc27524ef6f2eefa72aec7315dbde3b | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 3.95e-04 | 165 | 93 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-04 | 166 | 93 | 4 | 94a00edf66d54bc5f7343daea700ca26cf38fd90 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 167 | 93 | 4 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 167 | 93 | 4 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-04 | 168 | 93 | 4 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 93 | 4 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-04 | 169 | 93 | 4 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.62e-04 | 172 | 93 | 4 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-04 | 172 | 93 | 4 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.72e-04 | 173 | 93 | 4 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.72e-04 | 173 | 93 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.15e-04 | 177 | 93 | 4 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.15e-04 | 177 | 93 | 4 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.15e-04 | 177 | 93 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-04 | 178 | 93 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.02e-07 | 194 | 93 | 9 | 4312_DN | |
| Disease | creatinine measurement | KIF21B DPAGT1 ALMS1 SETBP1 PHTF2 KYAT3 RASL12 PRMT7 NFAT5 TUB KIAA1614 FAM83B | 4.94e-05 | 995 | 90 | 12 | EFO_0004518 |
| Disease | Myelomonocytic leukemia | 9.15e-05 | 5 | 90 | 2 | C0027019 | |
| Disease | N-acetyltyrosine measurement | 1.37e-04 | 6 | 90 | 2 | EFO_0020021 | |
| Disease | Leukemia, Myelocytic, Acute | 1.92e-04 | 173 | 90 | 5 | C0023467 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.55e-04 | 8 | 90 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | N-acetylkynurenine (2) measurement | 3.27e-04 | 9 | 90 | 2 | EFO_0800083 | |
| Disease | N-acetylleucine measurement | 3.27e-04 | 9 | 90 | 2 | EFO_0800116 | |
| Disease | N-delta-acetylornithine measurement | 5.95e-04 | 12 | 90 | 2 | EFO_0800067 | |
| Disease | response to calcium channel blocker | 6.77e-04 | 56 | 90 | 3 | EFO_0007767 | |
| Disease | N-acetylglutamine measurement | 7.02e-04 | 13 | 90 | 2 | EFO_0800017 | |
| Disease | inositol measurement | 8.17e-04 | 14 | 90 | 2 | EFO_0010504 | |
| Disease | urinary metabolite measurement | 9.38e-04 | 245 | 90 | 5 | EFO_0005116 | |
| Disease | N-acetylarginine measurement | 1.07e-03 | 16 | 90 | 2 | EFO_0021429 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.14e-03 | 67 | 90 | 3 | C3463824 | |
| Disease | RS-6-hydroxywarfarin measurement | 1.32e-03 | 155 | 90 | 4 | EFO_0803328 | |
| Disease | Juvenile Myelomonocytic Leukemia | 1.52e-03 | 19 | 90 | 2 | C0349639 | |
| Disease | diaphragmatic hernia | 1.86e-03 | 21 | 90 | 2 | EFO_0008561 | |
| Disease | blood urea nitrogen measurement | 2.63e-03 | 452 | 90 | 6 | EFO_0004741 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.04e-03 | 195 | 90 | 4 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GASQFETSAAKLKRK | 56 | Q15836 | |
| KRLGSLNKFKAKARS | 301 | Q9H0S4 | |
| SGSFVLFLKDGKLKL | 416 | Q9BZ76 | |
| NGKLKCAGSSLFLKR | 601 | Q8WWZ4 | |
| FLSDTLSLKGKKLDF | 21 | Q8IZF6 | |
| AKDFGIKRTIASKVS | 276 | Q2M3G0 | |
| LLKFSREKKAAKTLG | 261 | P35348 | |
| SKERSGVSLAALKKA | 51 | P16403 | |
| KKGLKASFSLSLTFT | 511 | A8K2U0 | |
| KLRKAPVKFASSSSV | 3236 | Q8TCU4 | |
| GLIKLAFLSSKTRCK | 26 | A6NHX0 | |
| SKKTGLTLLAAASIA | 151 | Q96IZ2 | |
| IKAGGSIAKKFSAAL | 216 | Q9NQ90 | |
| KKHSRAATGFLKLLA | 241 | Q8IYB7 | |
| AKGKTSEALAKLISL | 801 | Q04656 | |
| LKNFISKASRVGAFK | 536 | O95199 | |
| AGKSALTVKFLTKRF | 31 | Q9NYN1 | |
| KGLSGVSTKNFSFKR | 456 | Q9Y5P3 | |
| VKKFFSASSRVGSKK | 101 | Q9UJ41 | |
| AKGFFLRNKLRKSSL | 231 | Q9BXF6 | |
| GFKLSSLLKLADTKA | 316 | Q9C0D6 | |
| ILKLSSARGKAKAFS | 216 | Q8NH19 | |
| FKGLKRFSLSAKVVD | 1271 | Q86U86 | |
| AKKFSAVRISKGLSE | 616 | Q13823 | |
| KKAAGLESAATIRTK | 2946 | O95714 | |
| RSSSIASTLGLKKLF | 996 | Q5VZ46 | |
| SFLKKGSQKLRSLLS | 766 | Q5T0W9 | |
| FKTKSLSFLGTFILK | 321 | Q9H3H5 | |
| KKKGSSFQTVSALFR | 641 | P13535 | |
| LSSRGKKFASALSKF | 271 | Q16875 | |
| KKGASQSFSKAARLK | 901 | O75037 | |
| AGKTESTKLILKFLS | 161 | Q9HD67 | |
| GDFGISKILSSKSKA | 146 | Q86SG6 | |
| SSLASAGLKRDSKLK | 651 | O15083 | |
| LKGSLKRSAISAAKT | 266 | Q9BXS6 | |
| IAGSKKKSTRARLVF | 401 | O94916 | |
| KKKKASASSFAQGIS | 41 | Q6PI98 | |
| SLKSNKLKSARKFTF | 1501 | Q96QU1 | |
| SVSGLKKIFKLSAAV | 396 | Q9Y236 | |
| LKIKTASGRKKAFST | 226 | Q8NGY6 | |
| KRDLLIKAGSFKVAT | 356 | Q8IZJ4 | |
| KGGLKSVSLFTSKLA | 111 | Q9H7U1 | |
| SSAASHKLLRKIFKA | 431 | Q9NVM4 | |
| SAFISAAKKAKLRSN | 136 | Q5JV73 | |
| RKNSAVKSKSFLGLS | 156 | Q8TAL5 | |
| GLQKTFSKLTSRFTK | 531 | O15063 | |
| GLFSKFRKSLVSNKV | 286 | Q14534 | |
| STRIKKSKALSGFSL | 266 | P03951 | |
| TLLLATSLGKAASKF | 321 | Q9Y4F3 | |
| KKKRALASNTSFFSG | 1211 | Q2VIQ3 | |
| SKERSGVSLAALKKA | 51 | P10412 | |
| KRDSRKSSGFLNLIK | 1061 | Q5VZK9 | |
| SKLKRKLSCSFLVGA | 111 | O60676 | |
| TFLRKSLKAALKHLG | 521 | Q9HB96 | |
| ASKERSGVSLAALKK | 51 | P16402 | |
| SGKSSKALKILRRVA | 266 | Q8TCC7 | |
| RGLDALSKKAKASTV | 431 | Q92736 | |
| LDASKRAKNFVSSKG | 446 | Q92630 | |
| LSGRAKFLKTISSSK | 11 | Q6YP21 | |
| KFLKTISSSKILGFS | 16 | Q6YP21 | |
| SGSFVLFLKDGKLKL | 416 | Q96NU0 | |
| NSLLRRGASKKALSK | 2061 | Q14980 | |
| FKASGTIKKFRAGLS | 161 | Q2NL67 | |
| LSGRAQESKFSKALK | 406 | Q2WGJ9 | |
| DKATGKISKLGRSFT | 196 | Q9Y230 | |
| FLSGSKKAKNSIDKS | 256 | Q8N3S3 | |
| RALAAFLKKSGKLKV | 16 | P39019 | |
| GKEFRLRSAKKASAL | 951 | Q96DN5 | |
| SFSFSNKKLLGSKAL | 636 | O75151 | |
| AKKRVVFADSKGLSL | 81 | Q9UQK1 | |
| AATGKLKSFARKFIN | 456 | O75448 | |
| LISALKNLSSAKRKF | 46 | Q9UNA1 | |
| FCGFKSKSLSKRSLR | 661 | P53794 | |
| KSLKAKVNRGASFGS | 751 | Q8WXE9 | |
| SLLGKAAKRTSKEYL | 431 | Q6ZVT6 | |
| GKAIKLAKDVASLSS | 1301 | P35749 | |
| KKGIFSSLKGLDTLA | 761 | Q8IVF5 | |
| DLARGLKKSSSFSKF | 491 | Q2M3V2 | |
| AGRATKLKVSKFAIS | 951 | Q9BXM0 | |
| AKVLAKKGDAASLRT | 1056 | Q8TEQ6 | |
| TKASGATALLLLKRS | 356 | A8MV23 | |
| SELSKKKASALLFSS | 606 | Q9Y4E1 | |
| EGKKASKSRLRFSSS | 716 | Q92543 | |
| AKLLKKSASVQGFFL | 291 | Q8N4Q0 | |
| ASGAKLRQGFSKSSK | 206 | Q5TFG8 | |
| SELSKKKASALLFSS | 606 | Q641Q2 | |
| KKSKFSKAGFTALNA | 216 | Q9NPG3 | |
| VSKAALATKLLSLSG | 56 | Q8WWH5 | |
| KCSSLKRAKRSTFLG | 756 | Q9ULL1 | |
| LRNSAAKKRAKLSGS | 976 | Q9Y4F4 | |
| ATSDAVGSSLKKRFK | 1386 | Q9Y6X0 | |
| VFLLAGRKRKKSKTS | 296 | P50607 | |
| LAAAIAGAKLRKVSK | 226 | P50552 | |
| KAKALKRSFKSQAVG | 216 | Q8N5Q1 |